RTW INVESTMENTS, LP

Position in TNGX — Tango Therapeutics, Inc.

CIK 1493215 NEW YORK, NY

Position in TNGX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$434,533,381

+$156,284,411 QoQ

Shares Held

13,900,620

+4.5% QoQ

Ownership

8.24%

of shares outstanding

% of Portfolio

3.71%

of 13F equity value

Holder Rank

of 246 holders

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RTW INVESTMENTS, LP holds $9,530,420,260 across 63 Biotechnology names. TNGX ranks #7 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDGL	Madrigal Pharmaceuticals, Inc.	1,993,687	$1,070,510,234
2	ARGX	Argenx SE	709,446	$658,202,715
3	PTCT	Ptc Therapeutics, Inc.	7,746,415	$631,875,071
4	PTGX	Protagonist Therapeutics, Inc	5,061,175	$620,398,831
5	CGON	CG Oncology, Inc.	8,514,590	$604,961,619
6	INSM	INSMED Inc	4,842,880	$516,347,865
7	TNGX	Tango Therapeutics, Inc. This page	13,900,620	$434,533,381
8	SYRE	Spyre Therapeutics, Inc.	4,251,996	$377,492,204

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$434,533,381	13,900,620	+4.5%	Shares	Sole	2026-08-14
2026-03-31	$278,248,970	13,300,620	+791.9%	Shares	Sole	2026-05-15
2025-12-31	$13,212,280	1,491,228	-24.2%	Shares	Sole	2026-02-17
2023-12-31	$19,470,844	1,966,752	+987.7%	Shares	Sole	2024-02-14
2021-12-31	$1,978,159	180,819	-69.9%	Shares	Sole	2022-02-14
2021-09-30	$7,758,000	600,000	—	Shares	Sole	2021-11-15
2021-06-30 BCTG	—	600,000	0.0%	Shares	Sole	2021-08-13
2021-03-31 BCTG	—	600,000	0.0%	Shares	Sole	2021-05-14
2020-12-31 BCTG	—	600,000	0.0%	Shares	Sole	2021-02-16
2020-09-30 BCTG	—	600,000	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.